Industry › Healthcare & Pharm

Press Releases

TANAKA Contributes to Venture Capital Fund "DMC No. 1 Investment Limited Partnership" Aiming to Establish a Medical Venture Ecosystem in Japan

Dec 20, 2022 10:00 HKT/SGT

Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets

Dec 19, 2022 19:00 HKT/SGT

中国抗体荣获“第七届金港股”评选中“最具价值医药及医疗公司”奖项

Dec 19, 2022 14:57 HKT/SGT

中國抗體榮獲「第七屆金港股」評選中「最具價值醫藥及醫療公司」獎項

Dec 19, 2022 14:56 HKT/SGT

SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards"

Dec 19, 2022 14:55 HKT/SGT

覆盖「研发-生产-商业化」的综合性生物制药公司博安生物H股全球发售

Dec 19, 2022 10:27 HKT/SGT

覆蓋「研發-生產-商業化」的綜合性生物製藥公司博安生物H股全球發售

Dec 19, 2022 10:26 HKT/SGT

An Integrated Biopharmaceutical Company Covering "R&D- Production-Commercialization" Boan Biotech's Global Offering of H Shares

Dec 19, 2022 10:25 HKT/SGT

Prenetics收购行动基因首次公开招股后首宗并购交易势扩大癌症基因组学之份额

Dec 16, 2022 19:59 HKT/SGT

Prenetics收購行動基因首次公開招股後首宗並購交易勢擴大癌症基因組學之份額

Dec 16, 2022 19:58 HKT/SGT

Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics

Dec 16, 2022 19:57 HKT/SGT

Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years

Dec 16, 2022 10:00 HKT/SGT

자료 보고, 새로운 임상 시험 중 50%의 시험 장소가 아시아 태평양 지역에 위치

Dec 16, 2022 07:00 HKT/SGT

数据显示 50% 的新试验位于亚太地区

Dec 16, 2022 07:00 HKT/SGT

數據顯示 50% 的新試驗位於亞太地區

Dec 16, 2022 07:00 HKT/SGT

Data Shows 50% of New Trials Have Sites in Asia Pacific

Dec 15, 2022 10:00 HKT/SGT

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

Dec 14, 2022 22:45 JST

NLS Pharmaceutics、BVF Partners L.P.から第1トランシェで1,000万ドルを資金調達

Dec 14, 2022 22:30 JST

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

Dec 14, 2022 21:45 HKT/SGT

EC Healthcare wins "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022

Dec 14, 2022 21:38 HKT/SGT